Clinical Trials Logo

Clinical Trial Summary

1. Evaluate the effect of medical treatment and percutaneous transluminal pulmonary angioplasty on takayasu arteritis with pulmonary artery involvement 2. evaluate the efficacy of FAPI in predicting the activity and treatment efficacy of takayasu arteritis with pulmonary artery involvement


Clinical Trial Description

At baseline, FAPI and FDG are performed to evaluate the activity of takayasu arteritis with pulmonary artery involvement. FAPI is also used to predict the treatment efficacy and prognosis of takayasu arteritis with pulmonary artery involvement. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05388682
Study type Observational
Source Chinese Pulmonary Vascular Disease Research Group
Contact Zhihong Liu, doctor
Phone 86-010-88396589
Email zhihongliufuwai@163.com
Status Recruiting
Phase
Start date January 19, 2014
Completion date December 31, 2042